New poll reveals Americans' mixed views on weight-loss drugs for obesity treatment, especially regarding teen use.

The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but it's expensive.

The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive ...

A 5-year-old boy from Royal Oak was killed in an explosion while receiving hyperbaric oxygen therapy at a healthcare facility ...

More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with obesity or have a health condition ti ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

A chocolate recall was recently upgraded to warn consumers of a potential to “cause serious adverse health consequences of death.” ...

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.